SFC: CITIC 21st century violates the takeover code-Alibaba Alibaba acquired CITIC in 21st century-IT information
On May 19, the Hong Kong SFC 18th announcement, takeover panel ruled that Ali, Alibaba's health had violated the takeover code exempted by the cleaning trade null and void by the Alibaba group. Takeovers Panel found that Alibaba during acquisition, and a shareholder of CITIC in 21st century Chen wenxin concluded a number of agreements, eye to his acquisition of the sole owner of the Hebei medical technology. Chen wenxin is CITIC 21st century Executive Director and Vice Chairman Chen Xiao Ying's brother.
Takeover panel ruled that the company entered into several agreements with Chen wenxin constitutes a special deal with preferential terms that cannot be extended to all shareholders, in clear breach of the takeover code.
Takeover panel also ruled that Alibaba the cleaning trade exemptions granted be declared null and void, and thus (unless you get relief) to trigger a mandatory general offer liability.
Concessional terms, given the difficulty of access to Chen wenxin set exact value, and taking into account since its announcement wash transaction, CITIC in 21st century, the market value of the shares, takeover panel pointed out that, in this case, Alibaba to acquire CITIC 21st century most of the subscription price paid for the rights to add any additional value may not be a significant value, therefore waive the mandatory general offer liability.
On January 23, 2014, Ali into a text editor and close the Group Baba Yunfeng, for about HK $ 1.327 billion stake in CITIC in 21st century, Alibaba group holding 38.1%, Yunfeng holding 16.2%, the joint realization of holding. In October 2014, CITIC 21st century officially changed its name to Ali's health information technology co., Ltd. 2014 the asset sales of 100 million Hong Kong dollars (about 84 million yuan), net profit of 50 million Hong Kong dollars (about 41.815 million yuan).
After the deal is completed, Alibaba and Ma Yunfeng Fund arm of CITIC's stake in 21st century 54%.
CITIC business operations medicine of the 21st century regulatory codes, pharmaceutical and electronic monitoring of the operations of its network through acquisition of CITIC in 21st century, the company got the first qualification of third-party Internet drug sales platform. On February 20, 2016, the State food and Drug Administration's announcement to suspend electronic drug code, will start the operation of the third party responsible for Drug Administration codes, Ali, and have made it clear to recover health agent operation.
香港证监会：阿里巴巴收购中信21世纪违反收购守则 - 阿里巴巴,中信21世纪 - IT资讯
5月19日消息，香港证监会18日发布公告，收购委员会裁定阿里巴巴旗下的阿里健康违反收购守则，阿里巴巴集团所获清洗交易豁免无效。收购委员会发现，阿里巴巴在进行收购交易期间，与中信21世纪的一名股东陈文欣订立了若干协议，向他收购其独资拥有的河北慧眼医药科技。陈文欣是中信21世纪执行董事兼副主席陈晓颖的弟弟。
收购委员会裁定，阿里巴巴与陈文欣之间所订立的若干协议构成一项特别交易，当中附有不可扩展至全体股东的优惠条件，这显然违反了《收购守则》。
收购委员会还裁定，阿里巴巴获授予的清洗交易豁免因此被宣告无效，并因而（除非另行获得宽免）触发了强制全面要约责任。
鉴于难以对陈文欣所获得的优惠条件设定确切价值，并考虑到自公布清洗交易以来，中信21世纪股份的市价水平，收购委员会指出，在此情况下，就阿里巴巴为收购中信21世纪的多数权益而支付的认购价增添的任何额外价值，极不可能会是一个重大数值，因此宽免了相关强制全面要约责任。
2014年1月23日，阿里放入正文编辑器并关闭巴巴集团联手云锋基金，以约13.27亿港元入股中信21世纪，阿里巴巴集团持股38.1%，云锋基金持股16.2%，联合实现控股。2014年10月，中信21世纪正式更名为阿里健康信息技术有限公司。该资产2014年主营业务收入1亿港元（约合0.84亿元人民币），净利5000万港元（约合4181.50万元人民币）。
收购交易完成后，阿里巴巴和马云旗下的云峰基金对中信21世纪的持股比例超过54%。
中信21世纪的主业为运营药品监管码，其旗下运营的中国药品电子监督网，借收购中信21世纪，阿里巴巴拿到了国内第一张第三方互联网售药平台资质。但2016年2月20日，国家食药总局发布公告，暂停执行电子药监码，将启动第三方来负责电子药监码运营，并已明确收回阿里健康方面的代理运营权。